Others have shown similar results in cats with breast cancer, where increased levels of VEGF-A, VEGFR-1 and VEGFR-2 were found especially in higher malignancy mammary carcinomas, such as HER2-positive and TN normal-like carcinomas [41]. This evidence concerns the gene FLT1 and breast carcinoma.